13.05.2011 • News

Momentive Reports Strong Q1

Momentive Specialty Chemicals  (formerly Hexion Specialty Chemicals) has reported revenues of $1.4 billion Q1 2011, compared to $1.1 billion during the prior year period as sales continued to increase primarily due to volume gains and pricing actions including the contractual pass through of higher raw material costs. The company had an operating income of $120 million, compared to operating income of $63 million for the prior year period.

The Q1 2011 operating income rose significantly compared to the prior year due to higher volumes, improving margins and ongoing cost productivity programs. The company has also posted a net income of $63 million for the first quarter of 2011 versus net loss of $7 million in the prior year period. The Q1 2011 results reflected the same factors impacting operating income.

Segment EBITDA (earnings before interest, taxes, depreciation and amortization) totaled $180 million in the first quarter of 2011 compared to $116 million during the prior year period. In addition, the Momentive reported pro forma adjusted EBITDA for the last 12 months of $747 million, including savings of approximately $48 million that the company expects to achieve in connection with the shared services agreement that it entered into with MPM.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.